These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of serum on the antiviral and anticellular activities of mouse interferon. Kading VH, Blalock JE, Gifford GE. Arch Virol; 1978; 56(3):237-42. PubMed ID: 205196 [Abstract] [Full Text] [Related]
28. Mode of action and biological properties of insoluble interferon. Chany C, Ankel H, Galliot B, Chevalier MJ, Gregoire A. Proc Soc Exp Biol Med; 1974 Oct; 147(1):293-9. PubMed ID: 4373752 [No Abstract] [Full Text] [Related]
29. [Antiviral and anticellular activity of human leukocytic and fibroblastic interferons in homo- and heterologous cells]. Orlova TG, Zhdanov LV, Timofeev IV, Indikova IN, Mentkevich LM. Vopr Virusol; 1981 Oct; (4):404-7. PubMed ID: 6171095 [Abstract] [Full Text] [Related]
30. Association of mouse interferon with liposomes. La Bonnardière C. FEBS Lett; 1977 May 15; 77(2):191-6. PubMed ID: 193734 [No Abstract] [Full Text] [Related]
32. A microplaque reduction assay for human and mouse interferon. Campbell JB, Grunberger T, Kochman MA, White SL. Can J Microbiol; 1975 Aug 15; 21(8):1247-53. PubMed ID: 240500 [Abstract] [Full Text] [Related]
33. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors. Thacore HR, Youngner JS. Virology; 1973 Dec 15; 56(2):512-22. PubMed ID: 4357054 [No Abstract] [Full Text] [Related]